GPFT — Grapefruit USA Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $1.00m
- $4.96m
- $0.59m
Annual income statement for Grapefruit USA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.042 | 0 | 0.451 | 3.67 | 0.589 |
Cost of Revenue | |||||
Gross Profit | 0.028 | 0 | -0.257 | 0.28 | -0.53 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | -2 | 7.25 | 2.85 | -34.8 | 4.4 |
Operating Profit | 2.04 | -7.25 | -2.4 | 38.4 | -3.81 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2.85 | -8.13 | -4.6 | -4.06 | -5.51 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2.85 | -8.13 | -4.6 | -4.06 | -5.51 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 2.85 | -8.13 | -4.61 | -4.06 | -5.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2.85 | -8.13 | -4.61 | -4.06 | -5.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.03 | -0.234 | -0.029 | -0.088 | -0.008 |